Company: Diurnal (DNL)
Date: 19th May 2021
Time: 5pm – 6pm
Presenter: Martin Whitaker – CEO
Company Information: Founded in 2004, Diurnal is a UK-headquartered, European specialty pharma company developing hormone therapeutics for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency and hypogonadism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
This is a 3 step process:
1) Log in to your ShareSoc account or Join ShareSoc for free
2) Click ‘Submit’ on the form below
3) Click on the link on the next page to register with Zoom to COMPLETE THE REGISTRATION
Once you have registered fully with Zoom you will receive an email notification, as well as reminders 1 day and 1 hour before the event starts.